Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis
B.E. Strober; J.J. Crowley; P.S. Yamauchi; M. Olds; D.A. Williams
- 作者B.E. Strober; J.J. Crowley; P.S. Yamauchi; M. Olds; D.A. Williams
- 卷第165卷
- 期第3期
- 文件大小292.97KB
- 发表时间2011
- DOI10.1111/j.1365-2133.2011.10419.x
- 页码661-668